Shareholder Investigation of Sage Therapeutics

Robbins LLP is Investigating the Officers and Directors of Sage Therapeutics, Inc. (SAGE) on behalf of Shareholders

We are investigating whether certain officers and directors of Sage Therapeutics, Inc. breached their fiduciary duties to shareholders. Sage Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes medicines to treat central nervous system (CNS) disorders.

Sage Therapeutics, Inc. (SAGE) Shareholders Have Legal Options

Concerned shareholders of Sage Therapeutics, Inc. (SAGE) who would like more information about your rights and potential remedies can send us a message via the Shareholder Information Form below.

Send us a message for more information.

Protect your investments.

Sign up for free investment monitoring.

Stock Watch members receive free investment monitoring and notifications.  

Leave your details to get started

"*" indicates required fields

Ticker + Amount
This field is for validation purposes and should be left unchanged.

Skip to content